• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Email
  • Facebook
  • LinkedIn
  • Twitter
  • YouTube

International Alliance of ALS/MND Associations

  • Members' Login
  • Contact
  • Join the Alliance
  • Donate
  • Understanding ALS/MND
    • What is ALS/MND
    • Genetics
    • Diagnosis
    • Glossary
    • Navigating the Community
  • Find a Member Association
  • Support for PALS & CALS
    • Fundamental Rights for People with ALS/MND and Caregivers
    • Research
      • Voice Preservation
      • Open Science
        • Open Label Extension
      • Expanded Access
      • Understanding ALS/MND Research
      • Improving Regulatory Pathways
      • Right to Try
      • US FDA Orphan Drug Designation
      • Unproven (Off-Label) Treatments
    • Advocacy
      • Advocacy Toolkit
      • Emergency Preparedness Toolkit
      • Equitable Access to Therapies
      • Recommendations for Trial Sponsors
    • Clinical Care
      • Genetic Counselling & Testing
      • Mental Health Support
      • Nursing and Symptom Management
      • Nutrition and Swallowing
      • Occupational Therapy and Activities of Daily Living
      • Physiotherapy and Mobility
      • Respiratory Care
      • Speech Therapy and Communication
      • Support for Family & Caregivers
      • Technology
      • Global Clinic Locator
    • Drugs in Development
      • AB Science – Masitinib
      • BrainStorm Cell Therapeutics – NurOwn
      • Clene Nanomedicine – CNM-Au8
      • ILB – Tikomed
      • Kadimastem – AstroRx
      • Mitsubishi Tanabe Pharma America – Oral Edaravone
      • Neuronata-R/Lenzumestrocel
      • NeuroSense – PrimeC
      • Neuvivo – NP001
      • Prilenia Therapeutics – Pridopidine
      • SOD1 Therapies & Trials
      • SPG302
      • T Regulatory Cell Therapies
      • Ulefnersen – Ionis Pharmaceuticals
    • Approved Drugs
      • Nuedexta
      • Radicava/Edaravone
      • Riluzole/Tiglutik
      • Rozebalamin/Methylcobalamin
      • Tofersen/Qalsody
    • Drugs No Longer in Development
      • Amylyx – AMX0035
      • Collaborative Medicinal Development – CuATSM
      • Cytokinetics – Reldesemtiv
      • Orphazyme – Arimoclomol
      • TUDCA Trial
  • Support for Health Professionals
    • Breaking the News in ALS/MND
  • Events/Programs
    • Calendar of Events/Programs
    • Global Day Calendar
    • Alliance Meeting
    • Allied Professionals Forum
    • “Day in the Life Of” Suite
    • Alliance Webinars
    • ALS/MND Connect
    • March of Faces
    • Patient Fellows Program
    • Alliance Fellows
    • SEED Grant Program
    • International Symposium
  • About
    • Who We Are
    • ALS/MND Health Literacy Map
    • Board of Trustees
    • Councils, Forums & Committees
      • Scientific Advisory Council
      • PALS and CALS Advisory Council
      • Advocacy and Public Policy Forum
      • Research Directors Forum
      • Governance Committee
      • Finance Committee
    • Staff
    • History
    • Newsletter Archive
    • Awards
      • Forbes Norris Award
      • Humanitarian Award
      • Allied Health Professional Award
      • Student Innovation Award
  • Members
    • Member Registration
    • Forgot Password

Forum Guidelines

International Alliance of ALS/MND Associations › Forums › Member Forum › Forum Guidelines

  • This topic has 0 replies, 1 voice, and was last updated 9 years, 11 months ago by Admin.
Viewing 1 post (of 1 total)
  • Author
    Posts
  • August 15, 2016 at 9:48 am #2059
    Admin
    Keymaster

      While writing on the forum, we expect all members to treat one another with respect, even if we may disagree. Our Executive Director will moderate the forum to the best of her ability. Please alert Cathy (alliance@als-mnd.org) if anyone is misusing the forum. We hope this is a wonderful resource for all of our members.

      • This topic was modified 6 years, 4 months ago by International Alliance.
      • This topic was modified 6 years, 4 months ago by Admin.
    • Author
      Posts
    Viewing 1 post (of 1 total)
    • You must be logged in to reply to this topic.
    Log In

    Primary Sidebar

    • Camilla Heiberg Freiberg, Denmark

      Camilla Heiberg Freiberg, Denmark

    • Olga, Argentina

      Olga, Argentina

    • Steve Gallagher, Canada

      Steve Gallagher, Canada
      Picture1

    • Len Johnrose, England

      Len Johnrose, England

    • Jette Odgaard Villemoes, Denmark

      Jette Odgaard Villemoes, Denmark

    • Inta Grubb, Australia

      Inta Grubb, Australia

    • Barry de Reuver, Netherlands

      Barry de Reuver, Netherlands

    • Soledad Rodriguez, Spain

      Soledad Rodriguez, Spain

    • Den Haag, Netherlands

      Den Haag, Netherlands

    • Steven Spencer, New Zealand

      Steven Spencer, New Zealand

    • Carlos Alberto Báez Murillo, Colombia

      Carlos Alberto Báez Murillo, Colombia

    • Shay Rishoni, Netherlands

      Shay Rishoni, Netherlands

    • Ali Var, Turkey

      Ali Var, Turkey

    • Fabrice Kamp, Germany

      Fabrice Kamp, Germany

    • Enzo Maccarrone, Italy

      Enzo Maccarrone, Italy

    • Yessenia Hernandez Mendoza, Mexico

      Yessenia Hernandez Mendoza, Mexico

    • Liam Dwyer, England

      Liam Dwyer, England

    • Andrietta, Italy

      Andrietta, Italy
      Andrietta

    • Greg Heydet, USA

      Greg Heydet, USA

    • Kirsty Gerlach, New Zealand

      Kirsty Gerlach, New Zealand

    • Marcelo Farinelli, Brazil

      Marcelo Farinelli, Brazil

    • David Solomon, UK

      David Solomon, UK

    • Daniel Hare, USA

      Daniel Hare, USA

    • Mike Rannie, Canada

      Mike Rannie, Canada

    • Peng Yi-Wen, Taiwan

      Peng Yi-Wen, Taiwan

    • Wilfried Leusing, Germany

      Wilfried Leusing, Germany

    • Amparo Muriel Engativa, Colombia

      Amparo Muriel Engativa, Colombia

    • Ana María Zavala, Mexico

      Ana María Zavala, Mexico

    • Shaleen Latchman, Canada

      Shaleen Latchman, Canada

    • Carlos Gomez Matallanas, Spain

      Carlos Gomez Matallanas, Spain

    • Patrick Shuma, Kenya

      Patrick Shuma, Kenya

    • Christian Bär, Germany

      Christian Bär, Germany

    • Phil Rossall, UK

      Phil Rossall, UK

    • Liam Dwyer, England

      Liam Dwyer, England

    • Jeff Sutherland, Canada

      Jeff Sutherland, Canada
      jspic

    • Natalya Rybakova, Russia

      Natalya Rybakova, Russia

    • Rudiger Hanemann, Germany

      Rudiger Hanemann, Germany

    • Purningam Jacob, India

      Purningam Jacob, India

    • Hiroshi Matsuyama, Japan

      Hiroshi Matsuyama, Japan

    • Willi Klein, UK

      Willi Klein, UK

    • Gisli Jonasson, Iceland

      Gisli Jonasson, Iceland

    • Michael Lee, Australia

      Michael Lee, Australia

    • Semra Gokalp, Turkey

      Semra Gokalp, Turkey

    • Jose Rivero Muñoz, Mexico

      Jose Rivero Muñoz, Mexico

    • Chen Chun-Chin, Malaysia

      Chen Chun-Chin, Malaysia

    • Manuel Arn, Switzerland

      Manuel Arn, Switzerland

    • Elisabeth Zahnd, Switzerland

      Elisabeth Zahnd, Switzerland

    • Natalya Rybakova, Russia

      Natalya Rybakova, Russia

    • Marco Antonio Alvarez Mercado, Mexico

      Marco Antonio Alvarez Mercado, Mexico

    • Frank Taylor, USA

      Frank Taylor, USA

    Learn more about the March of Faces

    Footer

    Stay connected to the global ALS/MND community.

    Subscribe to receive our newsletter and updates on how to get involved across the Alliance network.

     
    This field is for validation purposes and should be left unchanged.
    • Email
    • Facebook
    • LinkedIn
    • Twitter
    • YouTube
    Return to top of page

    Contact | Disclaimer | Privacy Notice & Cookies | Sitemap

    Copyright © 2026 The International Alliance of ALS/MND Associations. All rights reserved.


    Registered in England: Charity Number 1079504 · Site built by graphics.coop · Powered by WordPress · Members' login